Precision radiation therapy for brain tumors from cancer
Part of Brain & nervous system, Cancer clinical trials.
This trial tests a new radiation therapy system called RayerKnife X to treat cancer that has spread to the brain. It aims to shrink the tumors with precise, high-dose radiation while reducing damage to healthy tissue, which may help control the disease and improve quality of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 80 years old.
- You should be able to take care of yourself and be up and about (though you may be slightly limited in activity).
- You must have cancer that has spread to your brain, with up to 10 tumors, each no larger than 4 cm (about 1.6 inches).
- You should not have had radiation to the same brain area before.
- You should not have had other cancer treatments (like chemotherapy, immunotherapy, or certain local treatments) very recently within 2–4 weeks before the study.
- You must be willing and able to follow the study plan, including signing a consent form and attending follow-up visits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests giving powerful, precise radiation (stereotactic radiosurgery) to large brain tumors before surgery, then using more radiation after surgery. It aims to see if this approach can control the tumor better while reducing side effects.
This trial compares two ways of giving focused radiation to the brain for people with a limited number of brain metastases. It aims to see which schedule works best (and is likely best for costs and quality of life).
This study tests a type of radiation treatment for people with one or more brain tumors that are larger than usual (2 to 5 centimeters). It aims to see if this approach is safe and effective, and may be an option if you are not having immediate surgery.
This Phase 2 study tests a precise, no-head-frame radiation technique to treat brain metastases. It may help by aiming radiation tightly at the tumors while limiting exposure to nearby healthy brain.
This study tests a type of radiation called stereotactic radiosurgery (SRS) given right after surgery to remove a brain tumor. The goal is to see if it helps control the tumor with fewer side effects.
This trial tests a new approach for people with a single large brain tumor that has spread from another cancer. You would receive a short, focused dose of radiation (stereotactic radiosurgery) in small, separate treatments, followed by surgery to remove the tumor. The goal is to see if this combination works better than the usual treatment.
Hear when a new Brain Metastasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.